Search

everythinglearnresearchcommunity

for

Search:↓

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Poly-D,L-lactic acid boosts hair growth in aged skin by activating hair follicle stem cells.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Major depression disorder increases the risk of alopecia areata, and vice versa.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Key proteins and potential drugs for treating alopecia areata were identified.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Veratric Acid may help promote hair growth and reduce hair loss.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Macrophages help maintain mammary stem cells and tissue balance through specific signaling pathways.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.